Notice: Trying to access array offset on value of type bool in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/functions.php on line 11

Deprecated: Methods with the same name as their class will not be constructors in a future version of PHP; dw_focus_categories_Widget has a deprecated constructor in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-categories.php on line 2

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-categories.php on line 435

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-recent-posts.php on line 524

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-recent-posts.php on line 525

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-recent-posts.php on line 526

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-slider.php on line 237

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-carousel.php on line 197

Deprecated: Methods with the same name as their class will not be constructors in a future version of PHP; dw_focus_tabs_Widget has a deprecated constructor in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-tabs.php on line 2

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-tabs.php on line 109

Deprecated: Methods with the same name as their class will not be constructors in a future version of PHP; dw_focus_accordion_Widget has a deprecated constructor in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-accordion.php on line 2

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-accordion.php on line 65

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-latest-headlines.php on line 144

Deprecated: Function create_function() is deprecated in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/inc/widgets/dw-focus-latest-comments.php on line 100

Deprecated: The called constructor method for WP_Widget in dw_focus_categories_Widget is deprecated since version 4.3.0! Use __construct() instead. in /home/banner/public_html/wp-includes/functions.php on line 4952

Deprecated: The called constructor method for WP_Widget in dw_focus_tabs_Widget is deprecated since version 4.3.0! Use __construct() instead. in /home/banner/public_html/wp-includes/functions.php on line 4952

Deprecated: The called constructor method for WP_Widget in dw_focus_accordion_Widget is deprecated since version 4.3.0! Use __construct() instead. in /home/banner/public_html/wp-includes/functions.php on line 4952

Notice: Trying to access array offset on value of type bool in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/header.php on line 9
Pre-Market: Redhill Biopharma Gets $2 Mln National Cancer Institute Grant For Myeloma Study - The Banner Herald

Pre-Market: Redhill Biopharma Gets $2 Mln National Cancer Institute Grant For Myeloma Study

Redhill Biopharma (RDHL) said it has received a $2 million grant from the National Cancer Institute to support its phase 2 study of Yeliva for refractory or relapsed multiple myeloma, to be initiated by RedHill at Duke University Medical Center by the end of 2015.
The study is expected to enroll up to 77 patients who have previously been treated with proteasome inhibitors and immunomodulatory drugs.

The primary objectives of the first portion of the study (Phase Ib) are to assess safety and determine the maximum tolerated dose in this group of patients. Secondary objectives include assessment of antitumor activity and determination of the pharmacokinetic (PK) and pharmacodynamic (PD) properties of Yeliva in refractory or relapsed multiple myeloma patients.

RDHL ADRs closed higher 5.2% on Tuesday, in the lower half of the 52-week range between $6.89 and $22.22. It was inactive in recent pre-market trade.


Notice: Trying to access array offset on value of type null in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/functions.php on line 1118

Notice: Trying to access array offset on value of type null in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/functions.php on line 1118

Notice: Trying to access array offset on value of type null in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/functions.php on line 1118

Notice: Trying to access array offset on value of type null in /home/banner/public_html/wp-content/themes/dw_focus_1.0.9_theme/functions.php on line 1118
Authors
Top